Figure 2From: Survival of gastrointestinal stromal tumor patients in the imatinib era: life raft group observational registry Overall survival: males vs. females. Females displayed significantly longer overall survival than males. This appears to be influenced by the long survival times and greater number of females in those with pediatric-type GIST. A smaller, but significant survival advantage was still noted for females > 35 at diagnosis (see Discussion)Back to article page